Mochi Health vs Henry Meds: Compounded GLP-1 Comparison

Mochi Health has built a reputation for aggressive pricing on compounded tirzepatide. The platform's startup costs are lean: no expensive initial consultation fees, just a standard telehealth assessment (often free or $50). Monthly medication costs are the real focus. Compounded tirzepatide typically starts around $150-180/month for lower doses and ranges up to $250+ for higher strengths.

Mochi's business model prioritizes volume and low margins. The company offers tirzepatide in multiple compounded formulations and has become the go-to choice for budget-conscious patients shopping for the lowest total monthly cost. Semaglutide is also available, typically priced similar to or slightly below tirzepatide depending on strength.

Henry Meds positions itself as a more premium service with stronger emphasis on medical supervision and ongoing support. Initial consultations typically cost $99-149, and the company may charge a monthly membership fee ($0-50 depending on plan) on top of medication costs. Compounded tirzepatide through Henry Meds runs $200-280/month, placing it at the higher end of the compounded market but still well below branded Zepbound.

The trade-off for Henry Meds' higher price is increased provider access, more frequent check-ins, and a more curated medication experience. If you value personalized medical oversight and don't want a purely transactional relationship, Henry Meds' premium is justified. Semaglutide pricing is comparable to tirzepatide.

Both Mochi Health and Henry Meds partner with licensed, regulated compounding pharmacies, so the medications themselves meet FDA compounding standards. However, there are subtle differences in formulation approach. Mochi works with compounders who focus on cost efficiency without sacrificing safety, resulting in consistent products at lower prices. Henry Meds may use compounders who emphasize formulation stability and shelf-life optimization, potentially commanding higher costs.

From a patient perspective, quality differences are minimal. The active ingredients (semaglutide or tirzepatide) are the same regardless of provider. Your experience and results depend more on dosing accuracy, proper storage, and consistent usage than on which compounder manufactures your medication.

Choose Mochi Health if price is your primary concern and you're comfortable with a more app-driven, transactional experience. Mochi is perfect for patients who want the absolute lowest monthly medication cost, have researched GLP-1 medications thoroughly, and don't need hand-holding from providers. You're willing to self-manage side effects and track your own progress.

Choose Henry Meds if you value ongoing provider relationship, regular check-ins, and a more medical approach to your weight loss journey. Henry Meds is ideal for patients new to GLP-1 therapy who want expert guidance, those managing significant health conditions, or anyone who prefers accountability and support from their provider. The premium is worth it if personalized care matters to you.